| Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man DR Matthews, JP Hosker, AS Rudenski, BA Naylor, DF Treacher, ... Diabetologia 28 (7), 412-419, 1985 | 28340 | 1985 |
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) UK Prospective Diabetes Study (UKPDS) Group The lancet 352 (9131), 837-853, 1998 | 20463 | 1998 |
| Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study IM Stratton, AI Adler, HAW Neil, DR Matthews, SE Manley, CA Cull, ... Bmj 321 (7258), 405-412, 2000 | 9702 | 2000 |
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) UK Prospective Diabetes Study (UKPDS) Group The Lancet 352 (9131), 854-865, 1998 | 7498 | 1998 |
| 10-year follow-up of intensive glucose control in type 2 diabetes RR Holman, SK Paul, MA Bethel, DR Matthews, HAW Neil New England Journal of Medicine 359 (15), 1577-1589, 2008 | 7266 | 2008 |
| Heart disease and stroke statistics-2017 update: a report from the American Heart Association. EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, J Floyd, ... circulation 135 (10), e146-e603, 2017 | 6426 | 2017 |
| Use and abuse of HOMA modeling TM Wallace, JC Levy, DR Matthews Diabetes care 27 (6), 1487-1495, 2004 | 4039 | 2004 |
| Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the … SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ... Diabetes Spectrum 25 (3), 154-171, 2012 | 3712 | 2012 |
| Publication bias in clinical research PJ Easterbrook, R Gopalan, JA Berlin, DR Matthews The Lancet 337 (8746), 867-872, 1991 | 2817 | 1991 |
| Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study AI Adler, IM Stratton, HAW Neil, JS Yudkin, DR Matthews, CA Cull, ... Bmj 321 (7258), 412-419, 2000 | 2618 | 2000 |
| Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) RC Turner, H Millns, HAW Neil, IM Stratton, SE Manley, DR Matthews, ... Bmj 316 (7134), 823-828, 1998 | 2521 | 1998 |
| Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European … SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ... Diabetes care 38 (1), 140-149, 2015 | 2511 | 2015 |
| Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the … SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ... Diabetologia 55 (6), 1577-1596, 2012 | 2260* | 2012 |
| Canagliflozin and cardiovascular and renal events in type 2 diabetes B Neal, V Perkovic, KW Mahaffey, D De Zeeuw, G Fulcher, N Erondu, ... New England Journal of Medicine 377 (7), 644-657, 2017 | 2171 | 2017 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 1940 | 2006 |
| Correct homeostasis model assessment (HOMA) evaluation uses the computer program JC Levy, DR Matthews, MP Hermans Diabetes care 21 (12), 2191-2192, 1998 | 1716 | 1998 |
| American Heart Association statistics committee and stroke statistics subcommittee EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... Heart disease and stroke statistics-2017 update: a report from the American …, 2017 | 1660* | 2017 |
| UK Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease UK Prospective Diabetes Study Group Diabetes 44 (11), 1249-1258, 1995 | 1538 | 1995 |
| Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in … M Nauck, A Frid, K Hermansen, NS Shah, T Tankova, IH Mitha, ... Diabetes care 32 (1), 84-90, 2009 | 1304 | 2009 |
| Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci JS Kooner, D Saleheen, X Sim, J Sehmi, W Zhang, P Frossard, LF Been, ... Nature genetics 43 (10), 984, 2011 | 1240* | 2011 |
